Skip to main content
SpringerLink
Log in

Myocardial Infarction and Viability With an Emphasis on Imaging Delayed Enhancement

  • Chapter
Cardiovascular Magnetic Resonance Imaging

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 2298 Accesses

Abstract

Cardiovascular magnetic resonance (CMR) is well suited to assessing patients with myocardial infarction. In a relatively short examination, CMR can assess myocardial anatomy, left ventricular function, perfusion, and viability—all with excellent image quality. Furthermore, the imaging planes can be programmed to provide identical views of the heart for each type of image. This facilitates intermodality comparisons.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56:786–794.

    PubMed  CAS  Google Scholar 

  2. Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40:633–644

    PubMed  CAS  Google Scholar 

  3. Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 2001;104:2981–2989.

    Article  PubMed  CAS  Google Scholar 

  4. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 1986;251:H1306–H1315.

    PubMed  CAS  Google Scholar 

  5. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003;83:1113–1151.

    PubMed  CAS  Google Scholar 

  6. Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 2004;95:125–134.

    Article  PubMed  CAS  Google Scholar 

  7. Christian TF, Clements IP, Gibbons RJ. Noninvasive identification of myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiograms with technetium-99m-Sestamibi. Circulation 1991;83:1615–1620.

    PubMed  CAS  Google Scholar 

  8. Aletras AH, Tilak GS, Natanzon A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T 2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113:1865–1870.

    Article  PubMed  Google Scholar 

  9. Anversa P, Kajstura J, Leri A, Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 2006;113:1451–1463.

    Article  PubMed  Google Scholar 

  10. Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation 2001;104:3158–3167.

    Article  PubMed  CAS  Google Scholar 

  11. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”. J Am Coll Cardiol 1986;8:1467–1470

    Article  PubMed  CAS  Google Scholar 

  12. Tarantini G, Cacciavillani L, Corbetti F, et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol 2005;46:1229–1235.

    Article  PubMed  Google Scholar 

  13. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765–772.

    PubMed  CAS  Google Scholar 

  14. Mollet NR, Dymarkowski S, Volders W, et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 2002;106:2873–2876.

    Article  PubMed  Google Scholar 

  15. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001;104:1280–1285.

    Article  PubMed  CAS  Google Scholar 

  16. Botnar RM, Perez AS, Witte S, et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004;109:2023–2029.

    Article  PubMed  CAS  Google Scholar 

  17. Botnar RM, Buecker A, Wiethoff AJ, et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 2004;110:1463–1466.

    Article  PubMed  Google Scholar 

  18. Spuentrup E, Buecker A, Katoh M, et al. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 2005;111:1377–1382.

    Article  PubMed  CAS  Google Scholar 

  19. Sirol M, Fuster V, Badimon JJ, et al. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 2005;112:1594–1600.

    Article  PubMed  Google Scholar 

  20. Pfeffer MA. Left ventricular remodeling after acute myocardial infarction. Annu Rev Med 1995;46:455–466.

    Article  PubMed  CAS  Google Scholar 

  21. Yousef ZR, Redwood SR, Marber MS. Postinfarction left ventricular remodeling: a pathophysiological and therapeutic review. Cardiovasc Drugs Ther 2000;14:243–252.

    Article  PubMed  CAS  Google Scholar 

  22. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44–51.

    Article  PubMed  CAS  Google Scholar 

  23. Wesbey GE, Higgins CB, McNamara MT, et al. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology 1984;153:165–169.

    PubMed  CAS  Google Scholar 

  24. McNamara MT, Tscholakoff D, Revel D, et al. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology 1986;158:765–769.

    PubMed  CAS  Google Scholar 

  25. Peshock RM, Malloy CR, Buja LM, Nunnally RL, Parkey RW, Willerson JT. Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion. Circulation 1986;74:1434–1440.

    Article  PubMed  CAS  Google Scholar 

  26. Rehr RB, Peshock RM, Malloy CR, et al. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. Am J Cardiol 1986;57:864–868.

    Article  PubMed  CAS  Google Scholar 

  27. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992–2002.

    PubMed  CAS  Google Scholar 

  28. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445–1453.

    Article  PubMed  CAS  Google Scholar 

  29. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215–223.

    PubMed  CAS  Google Scholar 

  30. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36:1985–1991.

    Article  PubMed  CAS  Google Scholar 

  31. Hsu LY, Natanzon A, Kellman P, Hirsch GA, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI. Part I: animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23:298–308.

    Article  PubMed  Google Scholar 

  32. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-d-old reperfused canine infarcts. Circulation 1995;92:1902–1910.

    PubMed  CAS  Google Scholar 

  33. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94:3318–3326.

    PubMed  CAS  Google Scholar 

  34. Decking UK, Pai VM, Wen H, Balaban RS. Does binding of Gd-DTPA to myocardial tissue contribute to late enhancement in a model of acute myocardial infarction? Magn Reson Med 2003;49:168–171.

    Article  PubMed  Google Scholar 

  35. Thornhill RE, Prato FS, Wisenberg G. The assessment of myocardial viability: a review of current diagnostic imaging approaches. J Cardiovasc Magn Reson 2002;4:381–410.

    Article  PubMed  Google Scholar 

  36. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105:224–229.

    Article  PubMed  Google Scholar 

  37. Maskali F, Poussier S, Marie PY, et al. High-resolution simultaneous imaging of SPECT, PET, and MRI tracers on histologic sections of myocardial infarction. J Nucl Cardiol 2005;12:229–230.

    Article  PubMed  Google Scholar 

  38. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445–1453.

    Article  PubMed  CAS  Google Scholar 

  39. Selvanayagam JB, Kardos A, Francis JM, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004;110:1535–1541.

    Article  PubMed  Google Scholar 

  40. Bello D, Fieno DS, Kim RJ, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005;45:1104–1108.

    Article  PubMed  Google Scholar 

  41. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004;109:2172–2174.

    Article  PubMed  Google Scholar 

  42. Nelson C, McCrohon J, Khafagi F, Rose S, Leano R, Marwick TH. Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography: a comparison with contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 2004;43:1248–1256.

    Article  PubMed  Google Scholar 

  43. Knuesel PR, Nanz D, Wyss C, et al. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 2003;108:1095–1100.

    Article  PubMed  Google Scholar 

  44. Kuhl HP, Beek AM, van der Weerdt AP, et al. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003;41:1341–1348.

    Article  PubMed  Google Scholar 

  45. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374–379.

    Article  PubMed  Google Scholar 

  46. Perin EC, Silva GV, Sarmento-Leite R, et al. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation 2002;106:957–961.

    Article  PubMed  Google Scholar 

  47. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002;106:2322–2327.

    Article  PubMed  CAS  Google Scholar 

  48. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162–167.

    Article  PubMed  Google Scholar 

  49. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21–28.

    Article  PubMed  CAS  Google Scholar 

  50. Ugander M, Cain PA, Perron A, Hedstrom E, Arheden H. Infarct transmurality and adjacent segmental function as determinants of wall thickening in revascularized chronic ischemic heart disease. Clin Physiol Funct Imaging 2005;25:209–214.

    Article  PubMed  Google Scholar 

  51. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004;109:2172–2174.

    Article  PubMed  Google Scholar 

  52. Geskin G, Kramer CM, Rogers WJ, et al. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 1998;98:217–223.

    PubMed  CAS  Google Scholar 

  53. Ibrahim T, Nekolla SG, Hornke M, et al. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol 2005;45:544–552.

    Article  PubMed  Google Scholar 

  54. Slomka PJ, Fieno D, Thomson L, et al. Automatic detection and size quantification of infarcts by myocardial perfusion SPECT: clinical validation by delayed-enhancement MRI. J Nucl Med 2005;46:728–735.

    PubMed  Google Scholar 

  55. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162–167.

    Article  PubMed  Google Scholar 

  56. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101–1107.

    Article  PubMed  CAS  Google Scholar 

  57. Beek AM, Kuhl HP, Bondarenko O, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003;42:895–901.

    Article  PubMed  Google Scholar 

  58. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253–2259.

    Article  PubMed  Google Scholar 

  59. Baks T, van Geuns RJ, Duncker DJ, et al. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol 2006;47:721–725.

    Article  PubMed  CAS  Google Scholar 

  60. Baks T, van Geuns RJ, Biagini E, et al. Recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 2005;26:1070–1077.

    Article  PubMed  Google Scholar 

  61. Ibrahim T, Nekolla SG, Hornke M, et al. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol 2005;45:544–552.

    Article  PubMed  Google Scholar 

  62. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253–2259.

    Article  PubMed  Google Scholar 

  63. Lund GK, Stork A, Saeed M, et al. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201T l SPECT imaging. Radiology 2004;232:49–57.

    Article  PubMed  Google Scholar 

  64. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083–1089.

    Article  PubMed  Google Scholar 

  65. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101–1107.

    Article  PubMed  CAS  Google Scholar 

  66. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103:2780–2783.

    Article  PubMed  CAS  Google Scholar 

  67. Gerber BL, Belge B, Legros GJ, et al. Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation 2006;113:823–833.

    Article  PubMed  Google Scholar 

  68. Selvanayagam JB, Porto I, Channon K, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 2005;111:1027–1032.

    Article  PubMed  CAS  Google Scholar 

  69. Hunold P, Schlosser T, Vogt FM, et al. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol 2005;184:1420–1426.

    PubMed  Google Scholar 

  70. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461–1474.

    Article  PubMed  Google Scholar 

  71. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T 2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004;109:2411–2416.

    Article  PubMed  Google Scholar 

  72. Garcia-Dorado D, Oliveras J, Gili J, et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res 1993;27:1462–1469.

    Article  PubMed  CAS  Google Scholar 

  73. Natanzon A, Aletras AH, Hsu LY, Arai AE. Determining canine myocardial area at risk with manganese-enhanced MR imaging. Radiology 2005;236:859–866.

    Article  PubMed  Google Scholar 

  74. Ni Y, Bormans G, Chen F, Verbruggen A, Marchal G. Necrosis avid contrast agents: functional similarity vs structural diversity. Invest Radiol 2005;40:526–535.

    Article  PubMed  CAS  Google Scholar 

  75. Pislaru SV, Ni Y, Pislaru C, et al. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation 1999;99:690–696.

    PubMed  CAS  Google Scholar 

  76. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539–542.

    Article  PubMed  Google Scholar 

  77. Amado LC, Gerber BL, Gupta SN, et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004;44:2383–2389.

    Article  PubMed  Google Scholar 

  78. Hsu LY, Ingkanisorn WP, Kellman P, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI. Part II: clinical application of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23:309–314.

    Article  PubMed  Google Scholar 

  79. Amado LC, Gerber BL, Gupta SN, et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004;44:2383–2389.

    Article  PubMed  Google Scholar 

  80. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47:372–383.

    Article  PubMed  Google Scholar 

  81. Gupta A, Lee VS, Chung YC, Babb JS, Simonetti OP. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology 2004;233:921–926.

    Article  PubMed  Google Scholar 

  82. Kellman P, Dyke CK, Aletras AH, McVeigh ER, Arai AE. Artifact suppression in imaging of myocardial infarction using B 1-weighted phased-array combined phase-sensitive inversion recovery dagger. Magn Reson Med 2004;51:408–412.

    Article  PubMed  Google Scholar 

  83. Kellman P, Chung YC, Simonetti OP, McVeigh ER, Arai AE. Multi-contrast delayed enhancement provides improved contrast between myocardial infarction and blood pool. J Magn Reson Imaging 2005;22:605–613.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. US Department of Health and Human Services, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland

    Andrew E. Arai MD (Senior Investigator)

Authors
  1. Andrew E. Arai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harvard Medical School, USA

    Raymond Y. Kwong MD, MPH (Instructor of Medicine and Director) (Instructor of Medicine and Director)

  2. Cardiac Magnetic Resonance Imaging, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts

    Raymond Y. Kwong MD, MPH (Instructor of Medicine and Director) (Instructor of Medicine and Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Arai, A.E. (2008). Myocardial Infarction and Viability With an Emphasis on Imaging Delayed Enhancement. In: Kwong, R.Y. (eds) Cardiovascular Magnetic Resonance Imaging. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-306-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-306-6_17

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-673-3

  • Online ISBN: 978-1-59745-306-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation